EUVIMEDEUVIMED entdecken
Open Access

Hypogonadism and neurocognitive outcomes among childhood cancer survivors

Tomoko Yoshida iD, Tyler Alexander iD, Mengqi Xing iD, Sedigheh Mirzaei, AnnaLynn M Williams iD, Margaret Lubas iD, Tara M Brinkman, Wassim Chemaitilly, Leslie L Robison iD, Melissa M Hudson iD, Kevin R Krull iD, Angela Delaney iD

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Tomoko Yoshida und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN 38105, United States. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms, Hypogonadism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, American Lebanese Syrian Associated Charities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Childhood cancer survivors are at risk for hypogonadism. The impact of hypogonadism on neurocognitive impairment and emotional distress in the non-cancer population has been shown; however, the relationship among the childhood cancer survivor population is unknown. We aimed to evaluate the contribution of hypogonadism to neurocognitive impairment and emotional distress among survivors.

Design

Cross-sectional study using retrospective cohort.

Methods

In total, 3628 survivors who completed standard neurocognitive tests (six domains: processing speed, memory, executive function, attention, academics, and global cognition) and self-reported emotional distress were included in our study. Participants were stratified by sex and gonadal status. Outcomes were compared between hypogonadal and eugonadal groups by multivariable analysis, adjusting for established predictors, and mediation analyses to determine the direct/indirect effects of hypogonadism on outcomes.

Results

The hypogonadal group exhibited a higher prevalence of neurocognitive impairment across domains, but no difference in emotional distress. Hypogonadal females exhibited higher relative risk (1.7, 95% CI, 1.2–2.5) for impaired visual processing speed, compared to eugonadal females after adjusting for cancer-related variables. In mediation models, hypogonadism had a significant direct (P < .01) and indirect (from P < .01) impact on impairment in visual processing speed among females. Males demonstrated direct (P = .03) and indirect (P = .04) impact of hypogonadism on motor processing speed.

Conclusion

Processing speed may be the most vulnerable neurocognitive domain associated with hypogonadism in survivors, while other domains were mainly impacted by cancer-related variables. Our findings support the need for further evaluation of the impact of sex hormone replacement therapy on neurocognitive function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsNeoplasmsHypogonadismMaleFemaleHumansChildRetrospective StudiesCross-Sectional Studies

Stichwörter der Autor:innen

childhood cancer survivorshormone replacement therapyhypogonadismneurocognitive dysfunctionsex hormone

Autor:innen und Institutionen

  • Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN 38105, United States.
  • Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 38105, United States.
  • Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, United States.
  • Division of Endocrinology and Diabetes, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, United States.
  • Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, United States.
  • Department of Pediatric Medicine-Endocrinology, St. Jude Children's Research Hospital, Memphis, TN 38105, United States.

ORCID-Profile: Tomoko Yoshida, Tyler Alexander, Mengqi Xing, AnnaLynn M Williams, Margaret Lubas, Leslie L Robison, Melissa M Hudson, Kevin R Krull, Angela Delaney

Förderung

  • NCI NIH HHS
  • American Lebanese Syrian Associated Charities

Zitieren

APA

Yoshida, T., Alexander, T., Xing, M., Mirzaei, S., Williams, A. M., Lubas, M., Brinkman, T. M., Chemaitilly, W., Robison, L. L., Hudson, M. M., Krull, K. R., & Delaney, A. (2024). Hypogonadism and neurocognitive outcomes among childhood cancer survivors. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae027

Vancouver

Yoshida T, Alexander T, Xing M, Mirzaei S, Williams AM, Lubas M, et al. Hypogonadism and neurocognitive outcomes among childhood cancer survivors. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae027

BibTeX
@article{Yoshida2024,
  author = {Yoshida, Tomoko and Alexander, Tyler and Xing, Mengqi and Mirzaei, Sedigheh and Williams, AnnaLynn M and Lubas, Margaret and Brinkman, Tara M and Chemaitilly, Wassim and Robison, Leslie L and Hudson, Melissa M and Krull, Kevin R and Delaney, Angela},
  title = {Hypogonadism and neurocognitive outcomes among childhood cancer survivors},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae027}
}
Kostenlos starten →